And that's why Merck could credibly become the next big weight-loss stock. Before you rush to go buy shares of Merck, ...

Biopharma stocks gained 9.6% in 2024, trailing the S&P 500’s 28.5% rise. Eli Lilly projects double-digit revenue growth ...

Vera Therapeutics' Atacicept has shown promising results in IgA nephropathy, leading to significant stock gains. But read why I'm cautious of entering VERA stock.

The US stock market will open for a half day session on Tuesday, December 24 and close early at 1 p.m. (EST). Christmas ...

Last year around this time, several leading drugmakers announced significant M&A deals to help fill their pipelines, including Bristol-Myers Squibb's (BMY) proposed takeovers of Karuna and RayzeBio, ...

The dvm360 editorial team is counting down our Top 20 news stories and articles of the year, from January 1, 2024, to ...

The Archibald Bulloch Chapter NSDAR recently presented the award-winning book “Historic Rural Churches of Georgia” to the ...

Laïd Zerhouni had a night to remember at KSW 101, the final event of the year for Poland’s KSW promotion. Held in Nanterre, ...